{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:58:00Z","timestamp":1777528680216,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011039","name":"Swiss Centre for Applied Human Toxicology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011039","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.tiv.2019.06.002","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T11:18:19Z","timestamp":1560165499000},"page":"261-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Bile salts regulate CYP7A1 expression and elicit a fibrotic response and abnormal lipid production in 3D liver microtissues"],"prefix":"10.1016","volume":"60","author":[{"given":"Catherine Jane","family":"Messner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Mauch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Suter-Dick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2019.06.002_bb0005","doi-asserted-by":"crossref","first-page":"349.1","DOI":"10.1096\/fasebj.24.1_supplement.349.1","article-title":"Bile acids increase proinflammatory gene expression in hepatocytes","volume":"24","author":"Allen","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.tiv.2019.06.002_bb0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajpath.2010.11.026","article-title":"Bile acids induce inflammatory genes in hepatocytes","volume":"178","author":"Allen","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0015","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/hep.26160","article-title":"Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells","volume":"57","author":"Anth\u00e9rieu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2019.06.002_bb0020","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1124\/dmd.114.058123","article-title":"Impact of inflammation on chlorpromazine-induced cytotoxicity and cholestatic features in HepaRG cells","volume":"42","author":"Azzi","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2019.06.002_bb0025","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tiv.2019.06.002_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.livres.2017.05.001","article-title":"Bile acid metabolism and signaling in liver disease and therapy","volume":"1","author":"Chiang","year":"2017","journal-title":"Liver Res."},{"key":"10.1016\/j.tiv.2019.06.002_bb0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2007.03.025","article-title":"Changes in classic and alternative pathways of bile acid synthesis in chronic liver disease","volume":"382","author":"Crosignani","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.tiv.2019.06.002_bb0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/BC20070127","article-title":"Which in vitro models could be best used to study hepatocyte polarity?","volume":"100","author":"Decaens","year":"2008","journal-title":"Biol. Cell."},{"key":"10.1016\/j.tiv.2019.06.002_bb0045","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/hep.23911","article-title":"Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver","volume":"52","author":"Denk","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2019.06.002_bb0050","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbrc.2012.07.029","article-title":"Tauro-\u03b2-muricholic acid restricts bile acid-induced hepatocellular apoptosis by preserving the mitochondrial membrane potential","volume":"424","author":"Denk","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tiv.2019.06.002_bb0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00441-011-1246-y","article-title":"TGF-\u03b2 in progression of liver disease","volume":"347","author":"Dooley","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.tiv.2019.06.002_bb0060","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1194\/jlr.M200489-JLR200","article-title":"Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice","volume":"44","author":"Erickson","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tiv.2019.06.002_bb0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.numecd.2018.09.006","article-title":"Lipoprotein-X fifty years after its original discovery","volume":"29","author":"Fellin","year":"2019","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.tiv.2019.06.002_bb0070","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jhep.2017.04.026","article-title":"Biliary bile acids in hepatobiliary injury \u2013 what is the link?","volume":"67","author":"Fickert","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0075","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/gast.2002.35948","article-title":"Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles","volume":"123","author":"Fickert","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tiv.2019.06.002_bb0080","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2353\/ajpath.2006.050404","article-title":"Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice","volume":"168","author":"Fickert","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10565-011-9208-4","article-title":"Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins","volume":"28","author":"Gerets","year":"2012","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0090","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tiv.2019.06.002_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/srep35434","article-title":"Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability","volume":"6","author":"Hendriks","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2019.06.002_bb0100","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00204-016-1814-8","article-title":"Adverse outcome pathway development from protein alkylation to liver fibrosis","volume":"91","author":"Horvat","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0105","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.emboj.7601049","article-title":"Endocrine functions of bile acids","volume":"25","author":"Houten","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.tiv.2019.06.002_bb0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/aivt.2018.0011","article-title":"Cholestatic drug induced liver injury: a function of bile salt export pump inhibition and farnesoid X receptor antagonism","volume":"4","author":"Jackson","year":"2018","journal-title":"Appl. Vitro Toxicol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0115","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-017-0161-7","article-title":"The roles of microRNA families in hepatic fibrosis","volume":"7","author":"Jiang","year":"2017","journal-title":"Cell Biosci."},{"key":"10.1016\/j.tiv.2019.06.002_bb0120","doi-asserted-by":"crossref","first-page":"G713","DOI":"10.1152\/ajpgi.00251.2017","article-title":"Hepatic stellate cells retain retinoid-laden lipid droplets after cellular transdifferentiation into activated myofibroblasts","volume":"315","author":"Jophlin","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4161\/rna.18827","article-title":"Liver-specific microRNA-122","volume":"9","author":"Jopling","year":"2012","journal-title":"RNA Biol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0130","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.3748\/wjg.14.5620","article-title":"Endocrine and paracrine role of bile acids","volume":"14","author":"Keitel","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/toxsci\/kfu269","article-title":"MicroRNA-122: a novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity","volume":"144","author":"Kia","year":"2015","journal-title":"Toxicol. Sci. Off. J. Soc. Toxicol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0140","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF00296964","article-title":"Drug-induced intrahepatic cholestasis: characterization of different pathomechanisms","volume":"60","author":"Krell","year":"1987","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0145","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejps.2006.01.004","article-title":"Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line","volume":"28","author":"Le Vee","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2019.06.002_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.11.026","article-title":"Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro","volume":"78","author":"Leite","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.tiv.2019.06.002_bb0155","first-page":"263","article-title":"Bile acid metabolism and signaling in cholestasis, inflammation and cancer","volume":"74","author":"Li","year":"2015","journal-title":"Adv. Pharmacol. San Diego Calif"},{"key":"10.1016\/j.tiv.2019.06.002_bb0160","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tiv.2019.06.002_bb0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mam.2017.06.001","article-title":"Mechanisms of bile acid mediated inflammation in the liver","volume":"56","author":"Li","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.tiv.2019.06.002_bb0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11938-001-0022-6","article-title":"Hyperlipidemia in chronic cholestatic liver disease","volume":"4","author":"Longo","year":"2001","journal-title":"Curr. Treat. Options Gastroenterol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0175","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4254\/wjh.v9.i12.586","article-title":"Role of circulating microRNAs in liver diseases","volume":"9","author":"Loosen","year":"2017","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193824","article-title":"Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans","volume":"13","author":"Luo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.tiv.2019.06.002_bb0185","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1152\/physrev.00061.2009","article-title":"Hepatocyte death: a clear and present danger","volume":"90","author":"Malhi","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tiv.2019.06.002_bb0190","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1172\/JCI108393","article-title":"Formation of lipoprotein-X. its relationship to bile compounds","volume":"57","author":"Manzato","year":"1976","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tiv.2019.06.002_bb0195","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0925-4439(02)00157-6","article-title":"Selective inhibition of CYP27A1 and of chenodeoxycholic acid synthesis in cholestatic hamster liver","volume":"1588","author":"Matsuzaki","year":"2002","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.tiv.2019.06.002_bb0200","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5114\/ceh.2018.80122","article-title":"The role of metabolic disorders in the pathogenesis of intrahepatic cholestasis of pregnancy","volume":"4","author":"Men\u017cyk","year":"2018","journal-title":"Clin. Exp. Hepatol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0205","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00204-012-0968-2","article-title":"Multi-cell type human liver microtissues for hepatotoxicity testing","volume":"87","author":"Messner","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0210","doi-asserted-by":"crossref","first-page":"58964","DOI":"10.1039\/C4RA09397F","article-title":"Control of cholesterol homeostasis by entero-hepatic bile transport \u2013 the role of feedback mechanisms","volume":"4","author":"Mishra","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.tiv.2019.06.002_bb0215","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/hep.25955","article-title":"Short-term feedback regulation of bile salt uptake by bile salts in rodent liver","volume":"56","author":"M\u00fchlfeld","year":"2012","journal-title":"Hepatol. Baltim. Md"},{"key":"10.1016\/j.tiv.2019.06.002_bb0220","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.cellsig.2008.06.014","article-title":"Bile acids and signal transduction: role in glucose homeostasis","volume":"20","author":"Nguyen","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.tiv.2019.06.002_bb0225","doi-asserted-by":"crossref","DOI":"10.1038\/srep38694","article-title":"Functional human induced hepatocytes (hiHeps) with bile acid synthesis and transport capacities: a novel in vitro cholestatic model","volume":"6","author":"Ni","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2019.06.002_bb0230","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/hep.23262","article-title":"Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice","volume":"51","author":"Osawa","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2019.06.002_bb0235","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1016\/j.atherosclerosis.2017.06.822","article-title":"New-onset severe hypercholesterolemia in a patient with cholestatic liver disease. Should we treat the lipids?","volume":"263","author":"Papakonstantinou","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tiv.2019.06.002_bb0240","doi-asserted-by":"crossref","first-page":"924","DOI":"10.5604\/16652681.1171785","article-title":"Severe hypercholesterolemia mediated by lipoprotein X in a patient with cholestasis","volume":"14","author":"Phatlhane","year":"2015","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179995","article-title":"Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis","volume":"12","author":"Prestigiacomo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.tiv.2019.06.002_bb0250","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/toxsci\/kfw069","article-title":"Cardiac non-myocyte cells show enhanced pharmacological function suggestive of contractile maturity in stem cell derived cardiomyocyte microtissues","volume":"152","author":"Ravenscroft","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2019.06.002_bb0255","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1124\/dmd.113.054205","article-title":"Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump","volume":"42","author":"Rodrigues","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2019.06.002_bb0260","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/labinvest.3780426","article-title":"Immortal activated human hepatic stellate cells generated by ectopic telomerase expression","volume":"82","author":"Schnabl","year":"2002","journal-title":"Lab. Investig."},{"key":"10.1016\/j.tiv.2019.06.002_bb0265","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2019.06.002_bb0270","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0016-5085(97)70239-7","article-title":"Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei","volume":"112","author":"Setchell","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tiv.2019.06.002_bb0275","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00535-017-1404-4","article-title":"Human hepatic stellate cell isolation and characterization","volume":"53","author":"Shang","year":"2018","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0280","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/toxsci\/kfu122","article-title":"Different dose-dependent mechanisms are involved in early cyclosporine A-induced Cholestatic effects in HepaRG cells","volume":"141","author":"Sharanek","year":"2014","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2019.06.002_bb0285","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.24538","article-title":"Circulating microRNAs as potential markers of human drug-induced liver injury","volume":"54","author":"Starkey Lewis","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2019.06.002_bb0290","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/clpt.2012.101","article-title":"Serum microRNA biomarkers for drug-induced liver injury","volume":"92","author":"Starkey Lewis","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"issue":"86","key":"10.1016\/j.tiv.2019.06.002_bb0295","article-title":"Combining extracellular miRNA determination with microfluidic 3D cell cultures for the assessment of nephrotoxicity: a proof of concept study","volume":"20","author":"Suter-Dick","year":"2018","journal-title":"AAPS J."},{"key":"10.1016\/j.tiv.2019.06.002_bb0300","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.gastro.2005.01.007","article-title":"Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor","volume":"128","author":"Svegliati-Baroni","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tiv.2019.06.002_bb0305","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2013.87","article-title":"MicroRNAs in liver disease","volume":"10","author":"Szabo","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059432","article-title":"Comparison of human hepatoma HepaRG cells with human and rat hepatocytes in uptake transport assays in order to predict a risk of drug induced hepatotoxicity","volume":"8","author":"Szabo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tiv.2019.06.002_bb0315","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/978-1-4939-2074-7_28","article-title":"Critical factors in the assessment of cholestatic liver injury in vitro","volume":"1250","author":"Woolbright","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0320","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.taap.2013.09.023","article-title":"Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice","volume":"273","author":"Woolbright","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0325","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.toxlet.2014.04.001","article-title":"Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice","volume":"228","author":"Woolbright","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tiv.2019.06.002_bb0330","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/bcpt.12449","article-title":"Bile acid-induced toxicity in HepaRG cells recapitulates the response in primary human hepatocytes","volume":"118","author":"Woolbright","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.tiv.2019.06.002_bb0335","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1478-3231.2011.02662.x","article-title":"Effect of bile duct ligation on bile acid composition in mouse serum and liver","volume":"32","author":"Zhang","year":"2012","journal-title":"Liver Int."},{"key":"10.1016\/j.tiv.2019.06.002_bb0340","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/jmcb\/mjw025","article-title":"Bile acids evoke placental inflammation by activating Gpbar1\/NF-\u03baB pathway in intrahepatic cholestasis of pregnancy","volume":"8","author":"Zhang","year":"2016","journal-title":"J. Mol. Cell Biol."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233319302760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233319302760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:34:35Z","timestamp":1760135675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233319302760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":68,"alternative-id":["S0887233319302760"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2019.06.002","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bile salts regulate CYP7A1 expression and elicit a fibrotic response and abnormal lipid production in 3D liver microtissues","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2019.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}